Clinical Trials on Diabetes Mellitus Type II in Russian Federation

Total 403 results

Besins Healthcare

Completed

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus (DESTINY)

Hypogonadism | T2DM (Type 2 Diabetes Mellitus)

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

Type II Diabetes Mellitus

Russian Federation
Research Clinical Centre of the Russian Railways...

Unknown

Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

Diabetes Mellitus | Hypoglycemic Episodes

Russian Federation
Novartis Pharmaceuticals

Completed

Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.

Type 2 Diabetes Mellitus (T2DM)

Russian Federation
Novo Nordisk A/S

Completed

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (PREDICTIVE™)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Russian Federation
Sanofi

Completed

Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...
Tameside Hospital NHS Foundation Trust

Completed

High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy

Diabetic Neuropathies | Vitamin D Deficiency | Diabetes Type 2

Russian Federation
Endocrinology Research Centre, Moscow

Completed

Evolution of Effectiveness of Diabetes Medical Care in Russia

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Russian Federation
AstraZeneca

Completed

Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)

Type 2 Diabetes

Russian Federation
Tomsk National Research Medical Center of the Russian...

Completed

Distal Renal Denervation to Prevent Renal Function Decline in Patients With T2DM and Hypertension (REFRAIN)

Hypertension | Type 2 Diabetes Mellitus

Russian Federation
Institute for Atherosclerosis Research, Russia

Completed

Cocarnit Effects on Macrophages Polarization (COMP-DM)

Diabetes Mellitus, Type 2 | Diabetes Complications

Russian Federation
AstraZeneca

Completed

Study With Dapagliflozin (GLORIA)

Diabetes Mellitus Type 2

Russian Federation
Becton, Dickinson and Company

Completed

The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Lipohypertrophy

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies

Completed

The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients

Type 2 Diabetes

Russian Federation
AstraZeneca
Biocard

Completed

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Diabetes Mellitus, Type 2

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

Clamp Study

Russian Federation
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Russian Federation, Ukraine
Federal State Budgetary Institution, V. A. Almazov...

Unknown

Prognostic Predictors of Response to Hypoglycemic Therapy

Diabetes Mellitus, Type 2

Russian Federation
Sanofi

Completed

Insulin Glulisine, Diabetes Mellitus Type 1

Diabetes Mellitus, Type 1

Russian Federation
Sanofi

Completed

Glulisine + Lantus in Type I Patients

Diabetes Mellitus, Type 1

Russian Federation
Sanofi

Completed

Apidra Children & Adolescents Study

Diabetes Mellitus, Type 1

Russian Federation
Irina Ermolaeva

Recruiting

RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD (RE-ELECT)

Chronic Kidney Diseases | Atrial Fibrillation | T2DM (Type 2 Diabetes Mellitus)

Russian Federation
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment

Type 2 Diabetes Mellitus

Russian Federation, Poland
Astellas Pharma Inc

Completed

A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

Diabetes Mellitus Type 2

Russian Federation
Hoffmann-La Roche

Completed

A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Diabetes Mellitus Type 2

United States, Russian Federation
National Medical Research Center for Cardiology...
Ministry of Health of the Russian Federation

Completed

Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Heart Failure, Diastolic

Russian Federation
Astana Medical University

Unknown

"The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"

Type 2 Diabetes

Kazakhstan, Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Unknown

Study of the AFB and Stenting of the Iliac Arteries

Aorta-iliac Segment Lesion (C,D Type by TASC II)

Russian Federation
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin (IMPRESSION)

Type 2 Diabetes Mellitus

Russian Federation
Atlas Biomed

Completed

Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Genetic Predisposition | Metagenome

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Recruiting

The Study of Recommendation System DiaCompanion for Women With Gestational Diabetes Mellitus

Gestational Diabetes Mellitus (GDM)

Russian Federation
Sanofi

Completed

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled (LEGEND)

Type 2 Diabetes Mellitus

Lebanon, Russian Federation, Ukraine
MEDA Pharma GmbH & Co. KG

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

Diabetic Polyneuropathy

Israel, Russian Federation
Human Stem Cell Institute, Russia
Ryazan State Medical University; Vidnoe District Hospital

Completed

Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot

Ulcers Related to Diabetic Foot Syndrome

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Unknown

Genetic and Epigenetic Mechanisms of Developing Gestational Diabetes Mellitus and Its Effects on the Fetus

Gestational Diabetes Mellitus

Russian Federation
Geropharm

Unknown

Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

Type I Diabetes Mellitus

Russian Federation
Mannkind Corporation

Completed

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

Diabetes Type 2

Russian Federation
Abbott Nutrition

Completed

Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Russian Federation
Sanofi

Completed

Insulin Glulisine in Type 2 Diabetic Patients (Basal Plus)

Diabetes Mellitus, Type 2

Russian Federation, United States, United Kingdom
Endocrinology Research Centre, Moscow
Russian Science Foundation

Completed

Vitamin D Metabolism in Patients With Endocrine Disorders

Diabetes Mellitus, Type 1 | Primary Hyperparathyroidism | Acromegaly | Pituitary ACTH Hypersecretion

Russian Federation
Procter and Gamble

Completed

Weight Loss in Pre-diabetic, Obese Women

Obesity

Russian Federation
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Russian Federation
Sanofi

Completed

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
Sanofi

Completed

Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

United States, Canada, Brazil, Poland, Romania, Russian Federation, Ukraine
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

Diabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin Dependent

United States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
Sanofi

Completed

Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus (ATLAS)

Diabetes Mellitus, Type 2

Japan, Russian Federation, China, India, Pakistan, Philippines
Central Clinical Hospital w/Outpatient Health Center...

Unknown

Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

Diabetic Angiopathies | Peripheral Arterial Disease | Critical Limb Ischemia | Thromboangiitis Obliterans | Arteriosclerosis Obliterans

Russian Federation
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

Type II Diabetes Mellitus

United States, Russian Federation, Czech Republic, Hungary, Netherlands

Clinical Trials on Diabetes Mellitus Type II in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations